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Abstract 21 
Human cytomegalovirus (HCMV) causes a lifelong infection through establishment of 22 
latency. Although reactivation from latency can cause life-threatening disease, our 23 
molecular understanding of HCMV latency is incomplete. Here we use single cell RNA-24 
seq analysis to characterize latency in monocytes and hematopoietic stem and progenitor 25 
cells (HSPCs). In monocytes, we identify host cell surface markers that enable 26 
enrichment of latent cells harboring higher viral transcript levels, which can reactivate 27 
more efficiently, and are characterized by reduced intrinsic immune response that is 28 
important for viral gene expression. Significantly, in latent HSPCs, viral transcripts could 29 
be detected only in monocyte progenitors and were also associated with reduced immune-30 
response. Overall, our work indicates that regardless of the developmental stage in which 31 
HCMV infects, HCMV drives hematopoietic cells towards a weaker immune-responsive 32 
monocyte state and that this anergic-like state is crucial for the virus ability to express its 33 
transcripts and to eventually reactivate.  34 
Introduction 35 
Human cytomegalovirus (HCMV) is a prevalent pathogen of the beta-herpesvirus 36 
family, infecting the majority of the human population worldwide (Staras et al., 2006). 37 
Following primary infection, HCMV persists through the lifetime of the host by 38 
establishing latency. In the latent state, no viral progeny is produced but the virus 39 
maintains the capacity to reactivate. Reactivation in immunocompromised individuals, 40 
such as transplant recipients and HIV patients, leads to severe illness and mortality 41 
(Crough and Khanna, 2009). Despite the significant health burden that accompanies 42 
HCMV reactivation from latency, to date there is no treatment that targets the latent 43 
stage and the processes governing latency and reactivation are far from fully 44 
understood.  45 
HCMV has a wide cell tropism within its human host (Mocarski, E.S., Shenk, T., 2013), 46 
with most cell types supporting lytic replication (C. Sinzger et al., 2008). In contrast, 47 
latent infection has so far been characterized in cells of the early myeloid lineage, 48 
including CD34+ hematopoietic stem and progenitor cells (HSPCs) and CD14+ 49 
monocytes in vivo (Mendelson et al., 1996; Taylor-Wiedeman et al., 1991; Von Laer et 50 
al., 1995). Since CD14+ monocytes are short-lived cells it has been proposed that the 51 
latent reservoir resides in hematopoietic stem cells (HSCs) (Slobedman et al., 2010) and 52 
that latent monocytes support viral spread and persistence within the infected host 53 
(Stevenson et al., 2014). Latent cells in HCMV seropositive individuals are scarce and 54 
were estimated by PCR-driven in situ hybridization, at 1:10,000 to 25,000 with a copy 55 
number of 2 to 13 genomes per infected cell (Slobedman and Mocarski, 1999). Using 56 
highly sensitive methodologies, such as digital PCR, viral genomes were detected in 57 
less than half of seropositive individuals and viral load was estimated at less than 10 58 
genomes in 10,000 cells in most individuals (Jackson et al., 2017; Parry et al., 2016). 59 
Due to the scarcity of HCMV-infected cells in the natural context, in vitro HCMV 60 
infection of primary cells, mainly HSPCs and monocytes were developed as models. 61 
The caveat of these systems is their heterogeneity and the possibility that they may 62 
represent dynamic differentiation states. Additionally, although both models are being 63 
widely used, the differences between them are not well understood. 64 
It is becoming increasingly evident that the repertoire of viral genes expressed during 65 
latent infections is broader than initially appreciated (Cheng et al., 2017; Schwartz and 66 
Stern-Ginossar, 2019; Shnayder et al., 2018). Despite low expression of viral 67 
transcripts, a number of studies have described infection driven changes in host cells 68 
during HCMV latency (Chan et al., 2010; Kew et al., 2017; Reeves et al., 2012; 69 
Slobedman et al., 2002; Smith et al., 2007, 2004). Monocyte infection was proposed to 70 
promote differentiation to macrophages with specific polarization towards genes that 71 
mark M1 phenotype with some atypical attributes  (Chan et al., 2008; Smith et al., 72 
2004). On the other hand it was shown that the viral homolog of human interleukin-10, 73 
encoded by UL111A, polarizes monocytes into an anti-inflammatory M2 subset (Avdic 74 
et al., 2013).  The UL7 viral protein was found to bind Fms-like tyrosine kinase 3 75 
receptor (Flt-3R), inducing differentiation of HSPCs to monocytes and of monocytes to 76 
macrophages (Crawford et al., 2018). Finally, analysis of HCMV infected HSPCs 77 
revealed reprogramming of HSPCs into immune-suppressive monocytes (Zhu et al., 78 
2018). Thus, although it is clear that latent HCMV infection affects the differentiation 79 
state of infected HSPCs and monocytes, the nature of these effects is still enigmatic and 80 
controversial.  81 
The studies to date examining host responses to latent HCMV infection focused on 82 
differences between infected and uninfected cells or on the effect of specific viral 83 
transcripts. Since the experimental systems for HCMV latency rely on primary immune 84 
cell populations, which are heterogeneous, and since infection is variable within the 85 
culture, it is likely that analyses of bulk populations could miss important signatures. 86 
Single cell-RNA-seq (scRNA-seq) provides a unique opportunity to depict viral and 87 
host heterogeneity simultaneously and thus to uncover functional connections between 88 
the cellular environment and viral gene expression. Indeed, several recent works that 89 
applied single cell transcriptomics, revealed novel  insights into the complexity of the 90 
host response and cellular permissiveness for a number of well-studied viruses (Douam 91 
et al., 2017; Drayman et al., 2019; Galinato et al., 2018; Rato et al., 2017; Russell et al., 92 
2018; Steuerman et al., 2018; Wyler et al., n.d.; Zanini et al., 2018).  93 
Using single cell RNA data, we analyzed host determinants that are associated with 94 
HCMV latency. In CD14+ monocytes, we identified two cellular cell surface markers, 95 
MHCII and its chaperon CD74, whose expression is inversely-correlated with viral 96 
transcript levels. We demonstrate these markers allow separating between cells 97 
harboring higher and lower viral transcript levels, that these differences are induced by 98 
HCMV infection and that the cells exhibiting higher viral transcript levels support more 99 
efficient reactivation of HCMV from latency. Using these markers, we show that 100 
latently infected cells display an intrinsic weaker immune response state that is 101 
important for the viral ability to express its genes and reactivate. Furthermore, analysis 102 
of 7500 infected HSPCs revealed very heterogeneous populations, but viral transcripts 103 
were only detected in cells expressing monocyte lineage markers, such as CD14. 104 
Remarkably, also in these HSPC-derived monocytes, higher viral transcript levels were 105 
associated with lower expression of CD74 and reduced immune response gene 106 
signature. Taken together, our findings highlight cell surface proteins associated with 107 
viral transcript levels and establish that both HSPC and monocyte infection models lead 108 
to establishment of HCMV latency in a similar anergic-like state of monocytic cells.  109 
Results 110 
Expression of host genes correlates with viral transcript levels 111 
We have previously performed  single cell RNA sequencing (scRNA-seq) on HCMV 112 
infected CD14+ monocytes as a model for studying HCMV latency (Shnayder et al., 113 
2018). We used the Massively Parallel RNA Sequencing (MARS-seq) platform (Jaitin 114 
et al., 2014; Paul et al., 2015) to analyze experimentally infected primary CD14+ 115 
monocytes at different days post infection (dpi). This approach provided high coverage 116 
of cellular and viral transcriptomes, spanning expression of more than 11,000 genes in 117 
3,655 cells. We previously used this dataset to examine the viral transcriptome during 118 
HCMV latency, showing it largely mirrors a late lytic viral program, albeit at much 119 
lower levels of expression (Shnayder et al., 2018).  120 
An inherent advantage of scRNA-seq is the ability to track viral and host expression 121 
within the same cell, thus allowing analysis of viral-host interactions while keeping 122 
information on cell-to-cell and infection heterogeneity. Viral transcript levels in the 123 
majority of the infected monocyte population was low to undetectable and projection of 124 
the cells using t-distributed stochastic neighbor embedding (t-SNE) demonstrated that 125 
the cell distribution is determined mainly according to host gene expression variations 126 
(Shnayder et al., 2018). Nevertheless, the cells are organized according to viral 127 
transcript levels (Shnayder et al., 2018 and Figure 1A), suggesting that much of the 128 
differences in host gene expression are associated with variation in viral transcript 129 
levels. We therefore calculated Spearman correlation coefficient between the expression 130 
of each host gene and the total number of viral transcripts across all cells (Figure 1B). 131 
319 cellular genes showed significant positive or negative correlations with viral gene 132 
expression (Z score>2, Figure 1- source data 1). Since a key challenge in transcriptome 133 
analysis is to connect between snapshots of gene expression profiles and a functional 134 
outcome, we first focused on identifying cell surface markers that exhibited strong 135 
association with viral gene expression in the scRNA-seq data as these may allow us to 136 
enrich for cells with higher viral transcript levels within the population. Among the 137 
strongest co-varying genes were genes encoding for MHC class II (variants HLA-138 
DRB1/ HLA-DPB1/ HLA-DRA/ HLA-DQB1/ HLA-DPA1/ HLA-DQA1/ HLA-DMA/ 139 
HLA-DRB5/ HLA-DQA2 and HLA-DMB) and the transcript of CD74, an MHCII 140 
chaperon as well as a cell surface receptor on its own (Bergmann, 2012).  Indeed, across 141 
the infected monocyte population, the expression level of MHC class II (MHCII, Figure 142 
1C) and CD74 (Figure 1D) showed clear inverse-correlation to viral transcript levels 143 
(Figure 1A). 144 
Cell-surface levels of CD74 and MHCII inversely-correlate with viral transcript 145 
levels  146 
Viral gene expression levels in latent infection decreases with time in culture, likely due 147 
to continuous repression of the viral genome. This time related reduction in viral 148 
transcript levels is also apparent in our CD14+ monocytes scRNA-seq data (Figure 1E), 149 
thus the increase in CD74 and MHCII expression could be related to time in culture and 150 
to only indirectly  inversely-correlate with viral transcript levels (Figure 1- figure 151 
supplement 1). Indeed, we observed that the expression of both CD74 and MHCII 152 
increase over time in culture, both in infected and in uninfected cells (Figure 1- figure 153 
supplement 2). We therefore tested whether this inverse-correlation between CD74 and 154 
MHCII expression and viral transcript levels is upheld within a single infected 155 
population at single time points. To this end, we infected primary CD14+ monocytes 156 
with HCMV strain TB40/E-GFP (O’Connor and Murphy, 2012; Christian Sinzger et al., 157 
2008). At 3 days post infection (dpi) the cells were FACS-sorted according to the cell-158 
surface levels of CD74 and MHCII (Figure 2A and Figure 2- figure supplement 1). RT-159 
qPCR analysis of viral gene expression in these populations confirmed that both 160 
CD74
low
 and MHCII
low
 monocyte populations express higher levels of viral transcripts 161 
compared to their high expressing counterparts (Figure 2B and Figure 2- figure 162 
supplement 1). Importantly, the association of higher viral transcript levels with lower 163 
cell-surface levels of CD74 was also maintained at 6dpi (Figure 2- Figure supplement 164 
2). We next examined if MHCII and CD74 are independent markers or are co-expressed 165 
and therefore mark the same population. mRNA expression analysis of CD74 and 166 
MHCII cells sorted according to the cell-surface levels of CD74 and MHCII as well as 167 
analysis of their co-expression in the scRNA-seq data, confirmed that the two markers 168 
are co-expressed and probably can be used to sort similar subpopulations within the 169 
infected cell population (Figure 2C and Figure 2- Figure supplement 3). We therefore 170 
conducted all further experiments using CD74 based sorts. qPCR Analysis of viral 171 
DNA levels demonstrated that higher viral transcript levels in CD74
low
 monocytes are 172 
concurrent with higher abundance of viral genomes (Figure 2D) suggesting that 173 
differential loads of viral genome templates probably contribute to differential viral 174 
transcript levels and therefore to the effect on the host. Finally, we examined CD74 cell 175 
surface expression in infected and uninfected cells at different time points post infection 176 
but no major changes in CD74 distribution following infection were observed (Figure 2- 177 
figure supplement 4).  178 
 179 
Changes in CD74 and MHCII expression are induced by infection 180 
There are two alternative explanations for the inverse-correlation between viral 181 
transcript levels and CD74 cell-surface levels, several days post infection with HCMV.  182 
The first possibility is that viral entry is more efficient in CD74
low
 monocytes compared 183 
to CD74
high
 monocytes, leading to more incoming viral genomes and higher viral 184 
transcript levels. In this case, differences in viral levels between CD74
high
 and CD74
low
 185 
monocytes should be evident immediately following viral entry to the cells. An 186 
alternative option is that the differential expression of CD74 is driven by HCMV 187 
infection. In this case, the viral DNA and RNA levels in early stages of infection should 188 
be independent of CD74 cell-surface levels, and at later time points, higher load of virus 189 
leads to the observed differences in CD74 expression. To test these possibilities, 190 
uninfected freshly isolated CD14+ monocytes were FACS sorted based on CD74 cell-191 
surface levels and then infected separately with TB40E-GFP. At 8 and 72 hours post 192 
infection (hpi) viral DNA and RNA were analyzed by qPCR.  We confirmed that indeed 193 
the CD74
high
 and CD74
low
 sorted cells exhibited differences in CD74 transcript levels 194 
negating the possibility that the separation is only due to variations associated with the 195 
cell surface staining (Figure 3A). No significant differences between viral DNA load 196 
(Figure 3B) or viral transcript levels (Figure 3C) in CD74
high
 and CD74
low
 monocytes 197 
were observed at either 8 or 72hpi, indicating there are no major differences in the 198 
efficiency of viral entry between the two populations. Taken together, these results 199 
indicate that the observed variation in CD74 cell-surface levels is induced following 200 
HCMV infection. 201 
 202 
CD74
low
 monocytes reactivate more efficiently 203 
An important characteristic that defines latent infection is the ability of the virus to 204 
reactivate. Therefore, a key challenge in gene expression analysis is to connect between 205 
snapshots of gene expression profiles and the infection status of the cells, which is 206 
defined by this functional outcome. The identification of cellular cell surface markers 207 
that inversely-correlate with viral transcript levels provides a handle to connect between 208 
gene expression and the ability of the virus to reactivate. To test the association between 209 
viral transcript levels and reactivation efficiency, HCMV infected primary CD14+ 210 
monocytes were sorted by CD74 cell-surface levels, and viral reactivation was induced 211 
by two complementary methods; cytokine driven differentiation to dendritic cells (DCs) 212 
(Reeves et al., 2005), followed by incubation with an indicator fibroblasts monolayer, or 213 
long term co-culturing with fibroblasts. Quantification of GFP positive plaques showed 214 
that reactivation was significantly more frequent in CD74
low
 cells compared to CD74
high
 215 
cells, in both protocols (Figure 4A and 4B). Lysed samples of monocytes plated onto 216 
indicator fibroblasts produced no plaques, confirming that these infected cells did not 217 
produce any detectable infectious virus, consistent with latency prior to reactivation 218 
induction. These results demonstrate a functional difference in reactivation efficiency 219 
associated with cell-surface CD74 levels as well as with viral transcript levels and 220 
genome load. 221 
 222 
CD74 can be used to enrich for HCMV harboring CD14+ monocytes from viremic 223 
patients 224 
Based on our experimental infection results, we next tested whether CD74 expression 225 
on CD14+ monocytes could be used as a cell surface marker that will allow enrichment 226 
of cells that contain HCMV genomes in healthy seropositive individuals. We used 227 
digital droplet PCR (ddPCR) to detect viral genome loads in CD14+ monocytes from 228 
seven seropositive donors. Despite using a highly sensitive platform (Figure 5- figure 229 
supplement 1) and detection of several positive events, testing 100,000-400,000 cells 230 
per donor did not provide us with levels of detection and reproducibility that allowed 231 
relative quantification (Figure 5- figure supplement 2A, 2B and Supplementary file 1). 232 
Recently, it was suggested that latent HCMV resides in a unique B7H4-positive 233 
monocyte subset (Zhu et al., 2018). To examine whether we can enrich for a cell 234 
population in which we can detect robust levels of HCMV genomes, we collected 235 
CD14+ monocytes from 5 healthy seropositive individuals. In all five donors we could 236 
not detect a distinct population of B7H4-positive cells (Figure 5- figure supplement 237 
2C). We nevertheless sorted the top 2% and the bottom 70% B7H4 stained cells and 238 
measured HCMV genome loads by ddPCR but did not detect higher levels of HCMV 239 
genomes in the top 2% B7H4 cells (Figure 5- figure supplement 2D). We therefore next 240 
analyzed CD14+ monocytes from seven hematopoietic stem cell transplant (HSCT) 241 
recipient samples in which HCMV viremia was detected, for the presence of viral 242 
genomes. In three of the tested samples no virus could be detected in CD14+ monocytes 243 
(Figure 5- figure supplement 2E).  Monocytes from the four additional samples, in 244 
which viral genomes were detected (Figure 5- figure supplement 2E), were sorted 245 
according to CD74 cell-surface levels (Figure 5A). In agreement with our results in the 246 
experimental infection model, CD74
 low
 monocytes were significantly enriched for the 247 
virus compared to CD74
high
 monocytes, illustrating that also in this natural infection 248 
setting, CD74 expression can be used to enrich for monocytes carrying viral genomes 249 
(Figure 5B and C). 250 
 251 
Cells with higher viral load express lower immune-responsive gene signatures 252 
To further characterize the differences in host pathways associated with the variations in 253 
viral transcript levels we conducted RNA-seq on latently infected monocytes, sorted 254 
according to their CD74 cell-surface levels. As was seen for single viral genes (Figure 255 
2B), we found that on a genome-wide level, viral gene expression is higher in CD74
low
 256 
cells compared to CD74
high
 cells (Figure 6A and Figure 6- figure supplement 1A). 257 
Furthermore, in accordance with our previous findings (Shnayder et al., 2018) the viral 258 
gene expression profile in these cells was correlated with late lytic profile (Figure 6- 259 
figure supplement 1B), but viral transcript levels were very low (~ 0.1% of mRNA 260 
reads originated from the virus). We performed differential gene expression analysis 261 
comparing between the CD74
low
 and CD74
high
 populations. This analysis revealed 113 262 
differentially expressed cellular genes (FDR<0.05, Figure 6- source data 1). Gene set 263 
enrichment analysis (GSEA) show that compared to CD74
low
,CD74
high
 monocytes, 264 
which exhibit lower viral transcript levels, are enriched for many immune response 265 
related pathways (Figure 6B and Figure 6- source data 2) including adaptive immune 266 
response and response to interferon gamma (Figure 6C). Since these cells were 267 
extracted from the same culture, these results suggest that monocytes carrying higher 268 
viral load are driven towards an intrinsic anergic-like phenotype. Reassuringly, many of 269 
the cellular genes and pathways exhibiting higher expression in CD74
high
 cells were also 270 
inversely-correlated with viral transcript levels in the scRNA-seq data (Figure 6D, 271 
Figure 6- figure supplement 2 and Supplementary file 2). The CD74
low
 monocyte 272 
population, which exhibits higher viral transcript levels, was enriched in genes that are 273 
related to transcription and virus life cycle (Figure 6B and Figure 6- source data 2). 274 
These pathways were not significantly correlated with viral expression levels in the 275 
single cell dataset, perhaps due to the sparser nature of our single cell measurements, 276 
which due to the sampling of limited number of cells may not detect some weaker 277 
effects.  278 
To decipher the differentiation status of latent monocytes we compared our data to a 279 
recently published single cell analysis of lineage commitment during hematopoiesis 280 
(Velten et al., 2017). The genes that showed elevated expression in the CD74
high
 cell 281 
population compared to the CD74
low
 population were enriched for genes associated with 282 
monocyte lineage priming (Figure 6E), implying that the cells exhibiting higher viral 283 
transcript levels express less commitment markers and therefore may represent a less 284 
differentiated state. Significantly, this gene signature of monocyte lineage priming was 285 
also inversely-correlated with viral transcript levels in the scRNA-seq data (Figure 6F). 286 
To further investigate the cell differentiation state, we analyzed gene sets that were 287 
previously associated with M1 or M2 polarization (Gerrick et al., 2018) and found that 288 
genes that were more highly expressed in CD74
high
 monocytes were significantly 289 
enriched for genes previously associated with M2 phenotype (Pval=2.25x10
-8
). This 290 
suggests that the infected CD14+ monocytes in our culture conditions may be polarized  291 
towards a cell-state associated with M2 phenotype, however higher viral transcript 292 
levels attenuates this differentiation trajectory. 293 
 294 
Inhibition of interferon signaling increases viral gene expression and reactivation 295 
Since a main feature of CD74
low
 monocytes is intrinsic reduced responsiveness to 296 
immune signals, we reasoned that this feature could contribute to the higher ability of 297 
the virus to express viral transcripts and eventually reactivate. To test this we examined 298 
whether inhibition of interferon signaling affects the expression level of viral transcripts 299 
and its ability to reactivate in infected CD14+ monocytes. We used ruxolitinib, a potent 300 
and selective Janus kinase (JAK) 1 and 2 inhibitor (Lin et al., 2009) that blocks the 301 
signaling downstream of interferon receptors. Treatment with ruxolitinib immediately 302 
after infection (3hpi) resulted in a considerable reduction in the levels of interferon-303 
induced genes at 3 and 6dpi (Figure 7A) and in increased expression of essentially all 304 
viral transcripts (Figure 7B), in an overall uniform manner (Figure 7- figure supplement 305 
1). In order to test how long after infection blocking interferon signaling still affects 306 
viral transcript levels, we applied ruxolitinib at different time points along infection and 307 
measured viral transcripts by RNA-seq. Interestingly, although the effect was smaller 308 
when the inhibitor was added later along infection, blocking interferon signaling still  309 
increased viral transcript levels even when added 3dpi (Figure 7C). These results 310 
therefore indicate there is continuous expression of viral genes and at 3dpi viral genes 311 
are still transcribed. However, the reduced effect of ruxolitinib with time also points 312 
that in addition there is gradual repression of viral gene expression as was also captured 313 
in our scRNA-seq analysis (Shnayder et al., 2018 and Figure 1E). Importantly, blocking 314 
interferon signaling led to more efficient reactivation of the virus (Figure 7D). This 315 
demonstrates that interferon signaling has a major role in repression of viral gene 316 
expression in infected monocytes and that the anergic-like state of monocytes exhibiting 317 
higher viral transcript levels is likely important for latency maintenance and 318 
reactivation.  319 
 320 
Viral transcript levels in HCMV-infected CD34+ HSPCs are associated with 321 
priming towards the monocyte lineage and reduced immune-response 322 
We have previously also performed scRNA-seq analysis of HCMV infected CD34+ 323 
HSPCs at 4dpi (Shnayder et al., 2018). To gain insight into the effects of HCMV on 324 
HSPC differentiation, we inferred differentiation trajectories using Monocle, a strategy 325 
that allows placing single cells along a pseudotime continuum based on their gene 326 
expression (Trapnell et al., 2014) (Figure 8A) . The cells expressing HCMV transcripts 327 
were clustered in a region that exhibited the latest pseudotime (i.e the most 328 
differentiated state, Figure 8B). Remarkably, although we infected bone marrow 329 
derived CD34+ HSPCs, viral transcripts were expressed only in cells expressing 330 
monocyte lineage markers (Velten et al., 2017), such as IRF7, IRF8 (Figure 8C) and 331 
CD14 (Figure 8D). Taking into account that it was previously shown that HCMV 332 
infects multipotent hematopoietic stem cells (Goodrum et al., 2004), these results 333 
indicate that HCMV induces differentiation of infected HSPCs towards the monocyte 334 
lineage. Interestingly, more detailed analysis of the distinct group of cells that 335 
expressed monocyte markers, revealed that this group could be split into two close yet 336 
distinct clusters, with viral reads being detected in much more cells in one of the 337 
clusters. Interestingly, the cluster showing higher viral transcript levels exhibited lower 338 
expression of CD74 (Pval=1.73x10
-95
, Figure 8E and 8F) as well as gene signatures 339 
associated with lower immune response to interferon gamma and lower adaptive 340 
immune response (Pval<0.001 and Pval=0.003, respectively, Figure 8G and 8H). Thus, 341 
cells within the HSPC population that exhibit the highest viral gene expression belong 342 
to the CD14+ monocyte cell lineage and are associated with similar anergic-like 343 
signatures as infected monocytes.  344 
Discussion 345 
HCMV establishes latency in its host in progenitor cells of the myeloid system 346 
(Mendelson et al., 1996; Taylor-Wiedeman et al., 1991; Von Laer et al., 1995). 347 
Nevertheless, in cell culture experimental systems it is apparent that not all cells have 348 
the ability to reactivate, indicating that there are variations in the levels or dynamics of 349 
latent infection. This heterogeneity means that bulk assays, comparing infected and 350 
uninfected cell populations can capture host responses to HCMV infection but likely 351 
miss specific responses in the group of cells in which latency is established, and will 352 
enable reactivation down the line.  353 
Recent single cell RNA-seq data portray low-level expression of a broad spectrum of 354 
canonical viral lytic genes during HCMV latent infection of various cells of the 355 
hematopoietic system (Galinato et al., 2018; Shnayder et al., 2018). Our analysis of 356 
latent HCMV infected CD14+ monocytes revealed a continuous population. 357 
Essentially, all of the cells were infected; however, they varied in the levels of viral 358 
transcripts.  We exploited the host and viral heterogeneity, revealed simultaneously in 359 
scRNA-seq data, to look for associations between viral transcript levels and the human 360 
transcriptome. We found that among the genes that were highly inversely-correlated 361 
with viral transcript levels, is a group of genes encoding MHCII as well as the cell 362 
surface marker CD74, which serves as an MHCII chaperone. The finding that there are 363 
host genes that show specific correlation with viral transcript levels indicates that there 364 
is direct interaction between the host and the virus during latent infection- either there 365 
is a preference of the virus to infect specific cell types or that the virus actively affects 366 
the host transcriptome. Indeed, these markers could be used to enrich for cells with 367 
increased viral genome load and viral transcript levels. Importantly, this was supported 368 
by analysis of CD14+ monocytes from viremic patients, which also shows a clear  369 
inverse-correlation between CD74 cell-surface levels and viral genome load. These 370 
results are in line with previous findings showing that human, murine and rat 371 
cytomegalovirus down regulate the surface expression of MHCII molecules in cells of 372 
the myeloid lineage  (Baca Jones et al., 2009; Elder et al., 2019; Lee et al., 2011; 373 
Slobedman et al., 2002; Yunis et al., 2018). In addition, CIITA, a transcription factor 374 
that regulates CD74 and MHCII, was shown to be down regulated by HCMV (Lee et 375 
al., 2011).  376 
The inverse-association between the expression of CD74 and MHCII and viral 377 
transcript levels could be related to differences in permissivity for the virus. By cell 378 
sorting according to CD74 levels prior to infection, we show that this is likely not the 379 
case; instead, these changes seem to be induced by viral infection. Moreover, we see 380 
that higher viral transcript levels in CD74
low
 cells is also accompanied by higher 381 
abundance of viral genomes, indicating that the level of viral transcripts is determined, 382 
at least initially, by the amount of incoming genomes, and this contributes to the extent 383 
of the effect on the host. Importantly, reactivation from HCMV latency happens in a 384 
very small population of cells even in experimental systems where the majority of cells 385 
are infected. We show here that CD74
low 
monocytes, which carry higher viral transcript 386 
and viral genome levels, reactivate more efficiently. This indicates that the ability of 387 
monocytes to reactivate is associated with viral transcript expression and that the cells 388 
carrying higher viral loads in these models are functionally the latent cell population, as 389 
they are more likely to reactivate. Recently, B7H4 was suggested as a marker for 390 
monocytes with higher levels of HCMV genomes from HCMV seropositive individuals 391 
(Zhu et al., 2018), however, we could not detect expression of B7H4 mRNA in any of 392 
our RNA-seq samples. Moreover, by staining for B7H4, we could not identify a distinct 393 
B7H4 positive monocyte population and did not detect higher levels of HCMV 394 
genomes in the top 2% B7H4 sorted cells. According to available human datasets, 395 
B7H4 is indeed not expressed in healthy monocytes (“Blood atlas - VTCN1 - The 396 
Human Protein Atlas”), however, these differences may stem from sampling of 397 
different donors or due to other variables related to the isolation of the cells.   398 
Our analysis indicates that the cells that have higher expression of viral genes are less 399 
immune-responsive including reduced response to interferons. Since the CD74
high
 and 400 
CD74
low
 monocytes we analyzed grew in the same culture, they were exposed to the 401 
same immune-extrinsic signals. Hence, this difference is intrinsic to specific cells, and 402 
may be actively induced by the virus. This is supported by a recent report showing that 403 
interferon induced genes are downregulated during latent infection of CD14+ 404 
monocytes (Elder et al., 2019). This anergic-like state is functionally related to the 405 
ability of the virus to express viral transcripts and to reactivate, as inhibiting the 406 
response to interferons resulted in increased expression of viral transcripts as well as 407 
increased reactivation efficiency. The importance of the role interferon plays in latent 408 
infection is further supported by the fact that CMV replication can be inhibited in 409 
otherwise permissive cells by treatment with interferon beta (Dağ et al., 2014). 410 
Similarly, extrinsic interferon stimuli inhibited HSV-1 reactivation from latency in 411 
neuronal cells (Linderman et al., 2017). Importantly, blocking interferon signaling 412 
increases viral gene expression even when done up to 3dpi, suggesting that there is 413 
continuous viral gene expression. However, the effect was smaller when the inhibitor 414 
was added later along infection, indicating a gradual repression of viral gene expression 415 
with time. Overall, these findings indicate that a major aspect of the maintenance of 416 
latency and of the ability to reactivate at the cellular level is a balance between 417 
opposing forces which also affect each other- the intrinsic immune response, 418 
specifically the interferon pathway, and viral transcript levels. Future work will have to 419 
delineate the mechanisms by which these immune response pathways control general 420 
viral transcription and how viral transcripts and viral proteins modulate the immune 421 
response during latent infection. 422 
Previous works have described changes in the differentiation state of monocytes in 423 
response to infection or to specific viral genes (Avdic et al., 2013; Chan et al., 2008; 424 
Smith et al., 2004). The use of the CD74 marker, allowed us to focus on differentiation 425 
processes unique to the CD14+ monocytes with higher viral transcript levels and higher 426 
reactivation efficiencies. We show that higher viral transcript levels are associated with 427 
less expression of monocyte priming signature and lower expression of a gene signature 428 
associated with M2 phenotype. It was previously shown that the HCMV encoded IL-10 429 
homolog polarizes monocytes towards an M2c macrophage phenotype (Avdic et al., 430 
2013). It is possible that the total population is indeed polarized towards this direction; 431 
however, this process may be inhibited in cells with higher viral transcript levels. These 432 
findings may suggest that the virus promotes attenuation of differentiation processes 433 
that monocytes are undergoing in culture and in the blood (Patel et al., 2017).  434 
Examining the differentiation state in HSPCs following infection is far more 435 
complicated than in monocytes, as CD34+ HSPCs are a mix of pluripotent cells as well 436 
as progenitor cells in different stages of lineage commitment (Velten et al., 2017). By 437 
applying single cell trajectory analysis, which allows recovery of gene expression 438 
kinetics of differentiating cells (Trapnell et al., 2014), and aligning our data with data of 439 
lineage commitment during hematopoiesis (Velten et al., 2017), we show that cells 440 
containing detectable viral transcripts belong largely to one specific population- cells 441 
primed towards the monocyte lineage. From our data, we cannot determine whether this 442 
is due to preferential infection by HCMV of monocyte lineage committed cells within 443 
the HSPC compartment or whether HCMV infects multipotent cells, which are then 444 
either preferentially skewed towards the monocytic lineage or viral gene expression is 445 
initiated only when cells start to differentiate in the monocytes lineage. However since 446 
it was previously demonstrated that multipotent cells are infected with HCMV 447 
(Goodrum et al., 2004), the latter options are more likely. Previous studies demonstrated 448 
that HCMV infection leads to an increase in monocyte markers (Zhu et al., 2018) and 449 
similar results were shown specifically for the viral gene UL7 (Crawford et al., 2018). 450 
Our results are in line with these studies and show directly and in an unbiased manner 451 
that several days post infection, viral gene expression can be found only in cells in the 452 
monocyte lineage. Moreover, within the monocyte lineage primed cells, the cells 453 
exhibiting higher viral transcript levels show the same markers and characteristics as we 454 
found when infecting CD14+ monocytes, primarily lower expression of CD74 and 455 
weaker immune responsiveness. This is especially interesting as it suggests that 456 
regardless of the developmental stage in which HCMV infects, the end point, a few 457 
days after infection, are cells with very similar characteristics.  458 
Overall, we use here single cell data to pinpoint the characteristics of the latently 459 
infected cells in an unbiased manner. Our analyses indicate that HCMV drives human 460 
HSPCs and monocytes into a monocyte state characterized by anergic-like gene 461 
signature.  These findings shed light on the characteristics of the latent reservoir, which 462 
may help in the effort of developing strategies to eradicate the latently infected cells.   463 
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Figure legends 473 
 474 
Figure 1: 475 
 476 
Cellular gene expression co-vary with viral transcript levels 477 
 (A) t-SNE plot of 3,416 latently infected CD14+ monocytes based on host and viral gene 478 
expression (Shnayder et al., 2018), colored by percentage of HCMV reads per cell. (B) 479 
Distribution of Z scores of the Spearman correlation coefficients between host transcript 480 
levels and total HCMV transcript levels across a single population of infected CD14+ 481 
monocytes. Black dots mark cells surface markers coding transcripts, blue marks CD74 482 
and red marks transcripts of MHCII (isoforms HLA-RB1/ HLA-DPB1/ HLA-DRA/ 483 
HLA-DQB1/ HLA-DPA1/ HLA-DQA1/ HLA-DMA/ HLA-DRB5/ HLA-DQA2 and 484 
HLA-DMB, left to right). (C and D)  t-SNE plots of monocytes as presented in A colored 485 
coded by their expression levels of MHCII (HLA-RB1/ HLA-DPB1/ HLA-DRA/ HLA-486 
DQB1/ HLA-DPA1/ HLA-DQA1/ HLA-DMA/ HLA-DRB5/ HLA-DQA2 and HLA-487 
DMB) (C) or CD74 (D) transcripts. (E) Percentage of viral reads measured in all single 488 
cells by days post infection (dpi). Error bars represent standard deviation across the single 489 
cells. 490 
 491 
Figure 2: 492 
CD74 and MHCII cell-surface levels in HCMV infected monocytes inversely-correlate 493 
with viral transcript levels 494 
(A) HCMV infected monocytes were FACS sorted according to cell-surface levels of 495 
CD74 or MHCII, at 3dpi. High and low gates were determined as highest and lowest 30% 496 
of the population, respectively. (B and C) Relative expression level of the viral transcripts 497 
RNA2.7 and UL138 (B) or MHCII and CD74 transcripts (C), as measured by RT-qPCR 498 
in HCMV infected cells, sorted by either MHCII (left) or CD74 (right) cell-surface levels 499 
at 3dpi. (D) Relative abundance of viral DNA in HCMV infected CD74
high 
and CD74
low
 500 
monocytes, at 3dpi as measured by qPCR. Graphs show a representative experiment of 3 501 
biological repeats, error bars reflect standard deviation of 3 measurements. P values as 502 
calculated by t-test are indicated. 503 
 504 
Figure 3: 505 
Changes in CD74 expression are induced by infection 506 
Uninfected primary monocytes were FACS sorted according to cell-surface levels of 507 
CD74. Equivalent numbers of CD74
high
 and CD74
low
 cells were infected with HCMV and 508 
differences in CD74 RNA levels and in viral DNA and RNA levels between these two 509 
cell populations were assessed by qPCR. (A) Relative CD74 transcript levels in CD74
high
 510 
and CD74
low
 cells at 8hpi. (B) Relative abundance of viral DNA in CD74
high
 and CD74
low
 511 
cells at 8hpi and 72hpi. (C) Relative expression level of the viral transcripts UL22A and 512 
RNA2.7 in CD74
high
 and CD74
low
 cells as measured at 8hpi and 72hpi. Graphs show a 513 
representative experiment of 3 biological repeats, error bars reflect standard deviation of 514 
3 measurements. P values were calculated by t-test and reflect non-significant 515 
differences. 516 
 517 
Figure 4: 518 
CD74
low
 infected monocytes reactivate more efficiently 519 
HCMV infected CD14+ Monocytes were sorted according to cell-surface levels of CD74 520 
at 3dpi. Equivalent numbers of cells were plated and (A) differentiated into DCs followed 521 
by co-culture with fibroblasts to quantify reactivation events or (B) directly co-cultured 522 
with fibroblasts to induce reactivation. Data is shown as number of infectious centers 523 
formed by CD74
high
 vs. CD74
low
 cells. Means and error bars (reflecting standard 524 
deviation) were generated from 4 independent experiments (A) and 3 independent 525 
experiments (B). Dot colors indicate sets from the same experiment. P values as 526 
calculated by t-test are indicated. 527 
 528 
Figure 5: 529 
CD74 cell-surface levels allow enrichment of CD14+ monocytes carrying HCMV 530 
genomes from viremic patients  531 
CD14+ monocytes from HSCT recipients with HCMV reactivation were sorted according 532 
to CD74 cell-surface levels. In total, 4 samples were tested, originating from 3 different 533 
donors (samples 1 and 2 were collected at different time points from the same donor), and 534 
viral genome abundance was measured by ddPCR. (A) A representative FACS sort of the 535 
cells. The highest and lowest 30% of the population were collected as CD74
high
 and 536 
CD74
low
 samples. (B) ddPCR results of two representative replicates from a single   537 
sample, separated by yellow vertical line. Upper panel shows detection of viral DNA, 538 
lower panel reflects detection of host genomes. The magenta line marks the threshold. 539 
(B) Quantification of viral genomes in CD74
high
 and CD74
low
 cells from four different 540 
samples, presented as copies per 10,000 cells. Graph reflects mean and 95% CV of 541 
poisson distribution, calculated from 5 technical replicates for each donor. P values as 542 
calculated by Fisher test are indicated. 543 
 544 
Figure 6: 545 
HCMV latency in monocytes is associated with reduced immune-response gene 546 
signatures 547 
RNA-seq was performed on HCMV infected CD14+ Monocytes that were sorted 548 
according to cell-surface levels of CD74 at 3dpi. (A) Normalized viral gene expression in 549 
CD74
high
 and CD74
low
 cells. P value calculated using likelihood ratio test on logistic 550 
regression of viral reads, is indicated. (B) Summary of gene set enrichment analysis 551 
(GSEA) of differential expressed genes identified in RNA-seq analysis of CD74
high
 and 552 
CD74
low
 cells using annotated GO biological processes and Reactome pathways. (C) 553 
Representative pathways from GSEA of genes ranked by their differential expression 554 
between CD74
high
 and CD74
low
 cells. (D) tSNE plot of scRNA-seq of latent monocytes 555 
colored by expression level of the pathways shown in C. (E) Monocyte priming gene set 556 
from (Velten et al., 2017) analyzed on GSEA. Genes are ranked by their differential 557 
expression between CD74
high
 and CD74
low
 monocytes. (F) tSNE plot of scRNA-seq of 558 
latent monocytes colored by the expression level of the monocyte priming gene set from 559 
(Velten et al., 2017). 560 
 561 
 562 
Figure 7: 563 
Inhibition of interferon signaling increases viral gene expression and promotes 564 
reactivation 565 
(A and B) HCMV infected monocytes were treated at 3hpi with interferon signaling 566 
inhibitor, ruxolitinib (ruxo), or left untreated, and analyzed for gene expression level, by 567 
RNA-seq.  (A) Expression of interferon-induced genes at 3dpi (left) and 6dpi (right). (B)  568 
Expression of viral genes at 3dpi (left) and 6dpi (right). (C) Viral gene expression in 569 
HCMV infected monocytes that were treated with ruxo at 1, 2, 3dpi or left untreated was 570 
measured by RNA-seq at 5dpi. P values for (A-C) calculated using likelihood ratio test 571 
on logistic regression of viral reads, are indicated. (D) HCMV infected monocytes were 572 
treated at 3hpi with interferon signaling inhibitor, ruxolitinib (ruxo), or left untreated, and 573 
at 6dpi, equivalent numbers of monocytes were co-cultured with fibroblasts to induce 574 
reactivation.  Viral reactivation in ruxo treated vs. untreated cells was assessed by count 575 
of GFP positive plaques formed on the fibroblasts. Means and error bars (reflecting 576 
standard deviation) were calculated from 2 independent biological repeats. P value as 577 
calculated using likelihood ratio test on Poisson regression of positive plaque events is 578 
indicated. 579 
 580 
Figure 8: 581 
Viral transcript levels in HCMV-infected CD34+ HSPCs is associated with priming 582 
towards the monocyte lineage and with reduced immune-response  583 
Pseudotime trajectory of single cell transcriptomes from HCMV infected CD34+ HSPCs 584 
(n= 7,634, (Shnayder et al., 2018)) colored by pseudotime (A), viral transcript levels (B), 585 
expression of monocyte priming gene signature (Velten et al., 2017)(C) and CD14 586 
expression (D). Zoom-in representation of the pseudotime trajectory in A-D, on the 587 
region exhibiting higher viral transcript level (top right group of cells) , colored by 588 
expression of CD74 (E), viral transcript levels (F), expression level of the cellular 589 
response to interferon gamma pathways (G) and of the adaptive immune response 590 
pathway (H). 591 
 592 
Supplementary figures: 593 
 594 
Figure 1- supplement 1: 595 
High association between the correlation of host gene expression vs. viral gene 596 
expression and host gene expression vs. time post infection  597 
Scatterplot showing correlation of host transcript levels and total HCMV transcript levels 598 
compared to correlation of host transcript levels and time along infection. 599 
 600 
Figure 1- supplement 2: 601 
CD74 and MHCII expression increases with culturing time of CD14+ monocytes 602 
Relative expression levels of CD74 (A) and MHCII (B) in HCMV infected cells and 603 
uninfected cells, measured by RT-qPCR at 6hpi, 3dpi and 6dpi. Error bars reflect 604 
standard deviation of 3 measurements. A representative analysis of two independent 605 
experiments is shown. 606 
 607 
Figure 2- supplement 1: 608 
CD74 and MHCII cell-surface levels in HCMV infected monocytes inversely-correlate 609 
with viral transcript levels 610 
HCMV infected monocytes were FACS sorted according to cell-surface levels of (A) 611 
MHCII or (B) CD74, at 3dpi. High and low gates were determined as highest and lowest 612 
30% of the population, respectively. Two biological repeats are shown. Viral expression 613 
levels in cells from each gate were assessed by RT-qPCR measurement of the viral 614 
transcript RNA2.7. Standard deviation and P values, by t-test, were calculated from 3 615 
technical replicates. 616 
 617 
 618 
Figure 2- supplement 2: 619 
Cell-surface CD74 levels in HCMV infected monocytes at 6dpi inversely-correlate with 620 
viral gene expression 621 
Expression level of viral transcripts RNA2.7 and UL138, as RT-qPCR measured in 622 
HCMV infected cells, sorted by CD74 cell-surface levels at 6dpi. Error bars reflect 623 
standard deviation of 3 technical replicates. P value, as calculated by t-test, is indicated. 624 
 625 
Figure 2- supplement 3: 626 
CD74 and MHCII genes are co-expressed in HCMV infected monocytes 627 
Scatterplot showing read number of CD74 vs. read number of MHCII genes in single 628 
HCMV infected monocytes according to scRNA-seq data (Shnayder et al., 2018).  629 
 630 
Figure 2- supplement 4: 631 
Surface expression distribution of CD74 does not change in uninfected and infected 632 
cell populations  633 
Infected (green) and uninfected (grey) cells were stained for surface expression of CD74 634 
and analyzed by flow cytometry at 0, 3 and 6dpi.  635 
 636 
Figure 5- supplement 1: 637 
Sensitivity of viral genomes detection by ddPCR 638 
Standard curve measuring the sensitivity and accuracy of viral DNA detection by ddPCR, 639 
using a CMV positive control template in copy number of: 1, 3, 6, 14, 35 and 140. 640 
Detection was possible down to 3 copies per sample.  641 
 642 
Figure 5- supplement 2: 643 
ddPCR analysis of natural  samples 644 
(A)  Analysis of samples from a healthy seropositive donor by ddPCR, done in eight 645 
replicates. Upper panel shows detection of viral DNA (1 positive event), lower panel 646 
reflects detection of host genomes. The magenta line marks the threshold. (B) Summary 647 
of all positive events detected in A. (C) Monocytes from 5 healthy seropositive 648 
individuals were FACS sorted according to B7H4 levels. A gate defining positive cells, 649 
as determined by minimal staining with isotype control (0.2%-0.8%) for each donor, and 650 
the sorting gates indicating the top 2% and bottom 70% are shown. (D) Quantification of 651 
viral genomes in the bottom 70% and top 2% B7H4 cells, designated as – and +, 652 
respectively, from 5 different donors, presented as copies per 10,000 cells. Graph reflects 653 
mean and 95% CV of poisson distribution, calculated from 2-4 technical replicates for 654 
each donor. (E) ddPCR analysis of monocytes from 7 samples originating from 6 HSCT 655 
patients with HCMV viremia. Each sample was tested in a duplicate for presence of viral 656 
genomes, shown separated by yellow vertical lines.  Monocytes from donors that were 657 
positive for viral genomes by ddPCR (samples 1-4) were used for CD74 analysis, as 658 
shown in Figure 5.  659 
 660 
Figure 6- supplement 1: 661 
Viral gene expression profile of infected CD14+ monocytes correlates between 662 
CD74
high
 and CD74
low
 cells and to late lytic profile 663 
Scatterplot showing read number of all viral genes in CD74high compared with CD74low cells 664 
at 3dpi (A). Scatterplot showing read number of all viral genes in CD74high+CD74low cells at 665 
3dpi compared to lytically infected monocyte-derived macrophages at 4dpi (B). 666 
 667 
Figure 6- supplement 2: 668 
Comparison of changes detected in bulk RNA-seq and scRNA-seq data 669 
Relationship between the fold changes in RNA-seq of CD74
high
 vs. CD74
low
 infected 670 
monocytes and correlation with viral transcript levels in infected monocyte scRNA-seq. 671 
Only genes that were differentially expressed in the bulk RNA-seq with P values< 0.01 672 
are shown.  673 
 674 
Figure 7- supplement 1: 675 
Uniform induction of expression across viral genes by inhibition of interferon 676 
signaling 677 
Scatterplot showing read number of all viral genes in ruxolitinib treated cells compared to 678 
untreated cells at (A) 3dpi and (B) 6dpi. 679 
 680 
Supplementary file 1 681 
ddPCR results of CD14+ monocytes from 7 donors 682 
Table showing the summary of ddPCR analysis of 8 samples from 7 healthy HCMV 683 
seropositive donors 684 
 685 
Supplementary file 2 686 
Correlation coefficients between CD74
high
 enriched pathways (Fig. 6B) and total 687 
HCMV transcript level across single infected CD14+ monocytes  688 
Materials and Methods 689 
Key Resources Table 
Reagent 
type 
(species) 
or 
resource 
Designation Source or reference Identifiers 
Additional 
informatio
n 
Cell line 
(Homo-
sapiens) 
Primary 
human 
foreskin 
fibroblasts 
(HFF) 
ATCC 
Cat#: CRL-
1634 
 
strain, 
strain 
backgroun
d (HCMV 
virus) 
TB40E-GFP 
O’Connor and Murphy, 2012; Christian Sinzger et al., 
2008 
  
Antibody 
anti-human 
APC-CD74 
(Mouse 
monoclonal) 
Miltenyi Biotec 
Clone: 5-329 
 
RRID:AB_265
9190 
1:200 
Antibody 
anti-human 
PE-HLA-DR, 
DP, DQ 
(recombinant) 
Miltenyi Biotec 
clone: 
REA332 
 
RRID:AB_265
2177 
 
1:200 
Antibody 
anti-human 
FITC-CD14 
(Mouse 
monoclonal) 
Miltenyi Biotec 
Clone: TÜK4 
 
RRID:AB_244
303  
1:200 
Antibody 
anti-human 
APC-B7H4 
(Mouse 
monoclonal) 
Biolegend 
clone: MIH43 
 
RRID:AB_256
2580 
1:200 
Antibody 
(isotype 
control) 
APC-Mouse 
IgG1 isotype 
control  
(Mouse 
monoclonal) 
Biolegend 
clone: MOPC-
21 
 
RRID:AB_3264
43 
1:200 
commerci
al assay or 
kit 
Human CMV 
HHV5 kit for 
qPCR using a 
glycoprotein B 
target 
 PrimerDesign 
 Cat#: Path-
HHV5  
commerci
al assay or 
kit 
HEX labeled 
RPP30 copy 
number assay 
for ddPCR 
Bio-Rad 
Cat#: 
dHsaCP10004
85 
 
chemical 
compound
, drug 
Ruxolitinib  InvivoGen Cat#: tlrl-rux 4µM 
peptide, 
recombina
nt protein 
Human GM-
CSF 
Peprotech 
Cat#: 300-03-
20 
1,000 U/
ml  
peptide, 
recombina
nt protein 
Human IL-4 Peprotech 
Cat#: 200-04-
20 
1,000 U/
ml 
biological 
compound 
(E.coli 
0111:B4) 
LPS Sigma cat#:  L4391 
500 ng/
ml 
software, 
algorithm 
R 3.5.1 
https://www.r-project.org/ 
 RRID:SCR_0019
05 
 
software, 
algorithm 
Monocle 2.10.1 
http://cole-trapnell-lab.github.io/monocle-release/ 
 2.10.1  
software, 
algorithm 
DESeq2 1.22.2 
https://bioconductor.org/packages/release/bioc/html/DES
eq2.html 
 
RRID:SCR_0156
87 
 
 
software, 
algorithm 
GSEA 3.0 
http://software.broadinstitute.org/gsea/index.jsp 
 
RRID:SCR_0031
99 
 
 
software, 
algorithm 
MSigDB 6.2 
 
http://software.broadinstitute.org/gsea/index.jsp 
 RRID:SCR_0168
63 
 
Database 
used for 
GSEA 
software, 
algorithm 
CellRanger 
2.0.0 
https://support.10xgenomics.com/single-cell-gene-
expression/software/pipelines/latest/what-is-cell-ranger 
 
RRID:SCR_0173
44 
 
 
software, 
algorithm 
lme4 1.1-21 
https://cran.r-project.org/web/packages/lme4/index.html 
 RRID:SCR_0156
54 
 
R package 
software, 
algorithm 
Bowtie2 2.2.9 
http://bowtie-bio.sourceforge.net/bowtie2/index.shtml 
  
software, 
algorithm 
Rtsne 0.15 
https://cran.r-project.org/web/packages/Rtsne/index.html 
 RRID:SCR_0163
42 
 
R package 
 690 
Cells and virus stocks 691 
Primary CD14+ monocytes were isolated from fresh venous blood, obtained from healthy 692 
donors, using Lymphoprep (Stemcell Technologies) density gradient followed by 693 
magnetic cell sorting with CD14+ magnetic beads (Miltenyi Biotec). The cells were 694 
cultured in X-Vivo15 media (Lonza) supplemented with 2.25mM L-glutamine at 37⁰C in 695 
5% CO2 (Fortunato, 2014). Primary human foreskin fibroblasts (HFF) (ATCC CRL-696 
1634) were maintained in DMEM with 10% fetal bovine serum (FBS), 2mM L-697 
glutamine, and 100 units/ml penicillin and streptomycin (Beit-Haemek, Israel).  698 
The  TB40E virus containing an SV40-GFP tag (TB40E-GFP) was described previously 699 
(O’Connor and Murphy, 2012; Christian Sinzger et al., 2008). Virus was propagated by 700 
electroporation of infectious bacterial artificial chromosome (BAC) DNA into fibroblasts 701 
using the Amaxa P2 4D-Nucleofector kit (Lonza) according to the manufacturer’s 702 
instructions.  Viral stocks were concentrated by centrifugation at 26000xg, 4⁰C for 120 703 
minutes. Infectious virus yields were assayed on THP-1 cells (ATCC TIB-202).  704 
 705 
Infection and reactivation procedures 706 
For experimental latent infection, CD14+ monocytes were incubated with the virus for 3 707 
hours, washed twice and supplemented with fresh media. To assess infection efficiency, a 708 
sample of the infected cell population was FACS analyzed for GFP expression at 3dpi. 709 
All experiments were conducted when there was a shift in GFP intensity of the entire 710 
population following infection, indicating all cells were infected. HCMV latency was 711 
validated by absence of GFP positive plaques on fibroblasts incubated with infected 712 
monocytes cell lysate. 713 
For reactivation assays, infected monocytes were counted, plated and co-cultured with 714 
primary fibroblasts immediately or following differentiation into dendritic cells (DCs). 715 
DC differentiation was done by incubation of cells with granulocyte-macrophage CSF 716 
and interleukin-4 (Peprotech) at 1,000 U/ml for 5 days, followed by stimulation with 717 
500 ng/ml of LPS (Sigma) for 48 hours (as previously described in (Cobbs et al., 2014)).  718 
Release of infectious virions was assayed by quantification of GFP positive plaques on 719 
the fibroblasts monolayer.  720 
 721 
Ruxolitinib treatment 722 
Ruxolitinib (Ruxo) was added at a concentration of 4uM, either immediately  after 723 
infection (3hpi) or at later time points (1, 2, or 3dpi). Monocytes were washed to remove 724 
residual Ruxo before co-culturing with fibroblasts. 725 
 726 
Quantitative real-time PCR analysis 727 
For analysis of RNA expression, total RNA was extracted using Tri-Reagent (Sigma) 728 
according to manufacturer’s protocol. cDNA was prepared using qScript cDNA 729 
Synthesis Kit (Quanta Biosciences) according to manufacturer’s protocol. For analysis of 730 
DNA levels, cells were lysed in a 1:1 mixture of PCR solutions A (100 mM KCl, 10 mM 731 
Tris–HCl pH 8.3, and 2.5 mM MgCl2) and B (10 mM Tris–HCl pH 8.3, 2.5 mM MgCl2, 732 
1% Tween 20, 1% Non-idet P-40, and 0.4 mg/ml Proteinase K), for 60 min at 60°C 733 
followed by a 10 min 95°C incubation, as described in (Roback et al., 2001). Real time 734 
PCR was performed using the SYBR Green PCR master-mix (ABI) on the QuantStudio 735 
12K Flex (ABI) with the following primers (forward, reverse): 736 
UL 138 (GTGTCTTCCCAGTGCAGCTA, GCACGCTGTTTCTCTGGTTA) 737 
UL22 (TTACTAGCCGTGACCTTGACG, CAGAAATCGAAGCGCAGCG)  738 
RNA 2.7 (TCCTACCTACCACGAATCGC, GTTGGGAATCGTCGACTTTG) 739 
CD74 (TGGAAGGTCTTTGAGAGCTGGATG, TTCCTGGCACTTGGTCAGTA) 740 
MHCII-HLA-DQA1 (CTTCATCATCCAAGGCCTGC, 741 
CGGGCCAGAGAATAGTGCTA) 742 
ANXA5 (AGTCTGGTCCTGCTTCACCT, CAAGCCTTTCATAGCCTTCC) 743 
Viral DNA was quantified with RNA2.7 primers, host DNA was measured with the 744 
following primers (forward, reverse): 745 
B2M (TGCTGTCTCCATGTTTGATGTATCT, TCTCTGCTCCCCACCTCTAAGT) 746 
 747 
Cell staining for flow cytometry and sorting 748 
Cells were counted, and stained in cold MACS buffer (PBS, 5% BSA, 2 mM EDTA). 749 
Cell staining was done using the following antibodies: anti-human APC-CD74 (Clone: 5-750 
329, Miltenyi Biotec), anti-human PE-HLA-DR, DP, DQ (clone: REA332, Miltenyi 751 
Biotec), anti-human FITC-CD14 (Clone: TÜK4, Miltenyi Biotec), anti-human APC-752 
B7H4 (clone: MIH43, Biolegend), APC-Mouse IgG1 isotype control (clone: MOPC-21, 753 
Biolegend)  according to manufacturer’s instructions. Cells were analyzed and sorted on 754 
a BD FACSAriaIII. 755 
 756 
Detection of viral genomes by digital PCR 757 
Detection of viral DNA in monocytes from natural latent samples was done using the 758 
QX200 droplet digital PCR system (Bio-Rad), using FAM labeled HCMV primer and 759 
probe (Human CMV HHV5 kit for qPCR using a glycoprotein B target (PrimerDesign) 760 
and HEX labeled RPP30 copy number assay for ddPCR (Bio-Rad), as previously 761 
described (Jackson et al., 2017). Calibration curve was ran in duplicate, using CMV 762 
positive control template (PrimerDesign). The limit of detection was at 3 events per 763 
sample, with accuracy improved at 10 copies and higher (Figure 5- figure supplement 1). 764 
For sample preparation cells were counted, dry pelleted, and stored at −80°C prior to 765 
DNA extraction. DNA was extracted from the cell pellet in a 1:1 mixture of PCR 766 
solutions A (100 mM KCl, 10 mM Tris–HCl pH 8.3, and 2.5 mM MgCl2) and B (10 mM 767 
Tris–HCl pH 8.3, 2.5 mM MgCl2, 0.25% Tween 20, 0.25% Non-idet P-40, and 0.4 768 
mg/ml Proteinase K), for 60 min at 60°C followed by a 10 min 95°C incubation, 769 
according to the description in (Roback et al., 2001).  770 
 771 
RNA library construction 772 
RNA libraries were generated from samples of ~10,000 cells according to the MARS-seq 773 
protocol (Jaitin et al., 2014; Keren-Shaul et al., 2019).  774 
 775 
Sequencing and data analysis 776 
RNA-Seq libraries (pooled at equimolar concentration) were performed in duplicates and 777 
sequenced using NextSeq 500 (Illumina), with read parameters: Read1: 72 cycles and 778 
Read2: 15 cycles. 779 
Analysis of bulk MARS-seq of CD14+ monocytes, sorted according to the CD74 cell-780 
surface levels, was done as described previously (Shnayder et al., 2018). The number of 781 
Unique Molecular Identifiers (UMIs) were: 976,294, and 947,474 for the CD74
high
 782 
samples, 902,150, and 844,872 for the CD74
low
 samples (Figure 6 A-E); 2,422,356 and 783 
2,395,329 for the –Ruxo 3dpi samples, 2,187,290 and 925,362 for the +Ruxo 3dpi 784 
samples, 4,228,168 and 3,854,339 for the –Ruxo 6dpi samples and  3,449,188 and 785 
1,900,301 for the +Ruxo 6dpi samples (Figure 7A and 7B); 2,076,741 and 1,858,871 for 786 
the +Ruxo at 1dpi samples, 1,914,289 and 1,163,469 for the +Ruxo at 2dpi samples, 787 
1,554,298 and 1,685,834 for the +Ruxo at 3dpi samples, 2,004,859 and 2,450,039 for the 788 
–Ruxo control (Figure 7C). 789 
Reads for gene expression and correlation analyses were normalized using DEseq2. 790 
Based on the t-SNE plot of the CD14+ monocyte cells in (Shnayder et al., 2018), the 791 
latent cells were defined as all cells besides the small distinct group of cells that show 792 
high levels of viral reads (mean 9.5%) . All the analyses in this paper include only the 793 
remaining 3,416 cells. 794 
 795 
Correlation and t-SNE coloring 796 
For calculating the Spearman correlation between host genes and either viral expression 797 
levels or dpi, in each cell, the sum of viral reads was normalized to the total number of 798 
reads in the cell, and the number of reads of each host gene was normalized to the total 799 
number of host reads in the cell. The correlation was calculated across 1,448 cells for 800 
6,997 genes. Cells with no viral reads, or with less than 700 different host genes 801 
expressed, were omitted. Genes with total number of reads less than 20 were ignored. 802 
The Z-score was calculated based on the mean and the standard deviation calculated over 803 
all 6,997 genes. 804 
Color coding of t-SNE (Figure 1C, Figure 6D and Figure 7B) or Monocle (e.g. Figure 805 
7C, G, H) plots for expression levels of groups of genes was calculated according to the 806 
average relative expression as follows: First, genes with low level of expression, i.e. 807 
expressed in less than 50 cells, were omitted. Next, the number of host reads per cell was 808 
normalized so that all cells will include the same number of reads. Next, for each cell and 809 
each gene, the relative expression is calculated as 𝑙𝑜𝑔2(
𝑟𝑖𝑗+1
𝑟?̅?+1
) where 𝑟𝑖𝑗 is the number of 810 
reads of gene 𝑖 in cell 𝑗 and  𝑟?̅? is the average number of reads of gene 𝑖 over all cells. 811 
Finally, for each cell the average 𝑙𝑜𝑔2 relative expression over all genes in the group was 812 
calculated. 813 
 814 
Differential Expression and Enrichment analysis 815 
The differential expression analysis was done with DESeq2 (version 1.22.2) (Love et al., 816 
2014) using default parameters, with the number of reads in each of the samples as an 817 
input. The normalized number of reads according to DESeq2 were used for enrichment 818 
analysis using GSEA (version 3.0) (Subramanian et al., 2005). The genes sets that were 819 
used were GO biological process (c5.bp) and REACTOME (c2.cp.reactome) from 820 
MSigDB (version 6.2) (Liberzon et al., 2011) and the monocyte progenitor gene list from 821 
(Velten et al., 2017). The GSEA plots were created based on the GSEA output with the R 822 
package enrichplot (Yu, n.d.). To calculate differential expression and pathway 823 
enrichment within the distinct group of cells that expressed monocyte priming markers, 824 
we used the graph-based clustering of the Cell Ranger software (“10x CellRanger 2.0.0,” 825 
n.d.), stratifying this group of cells into two distinct clusters and GSEA (version 3.0) 826 
(Subramanian et al., 2005) for pathway enrichment. Differential expression and 827 
enrichment analysis were done on these two clusters. Enrichment of M1 and M2 828 
associated genes was done by hypergeometric test taking all genes with mean expression 829 
>=5 as background.  830 
 831 
Monocle analysis 832 
CD34+ cells were ordered according to the predicted pseudo-time using Monocle 833 
(version 2.10.1) (Trapnell et al., 2014). The cells used in this analysis were filtered to 834 
have at least 1,000 expressed genes and not more than 10,000 UMIs, while the genes 835 
were filtered to have mean expression greater than 0.1, and empirical dispersion greater 836 
than the global dispersion fit. 837 
 838 
Ethics statement 839 
All fresh peripheral blood samples were obtained after approval of protocols by the 840 
Weizmann Institutional Review Board (IRB application 92-1). The study using HSCT 841 
recipient samples was approved by the Human Research Ethics Committee of the 842 
University of Sydney and the Western Sydney Local Health District. Informed consent 843 
was obtained from all study participants prior to enrolment in accordance with the 844 
Declaration of Helsinki.  845 
 846 
Data availability 847 
All next-generation sequencing data files were deposited in Gene Expression 848 
Omnibus under accession number GSE138838.  849 
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